Back to REGN
Candriam S.C.A. REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$131.8M
Q3 2026
Peak value
$158.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $95.3M |
| Q4 2025 | $158.5M |
| Q4 2025 | $158.5M |
| Q1 2026 | $144M |
| Q2 2026 | $121.9M |
| Q3 2026 | $131.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $131.8M | 173.1K | — | — |
| Q2 2026 | $121.9M | 195.7K | — | — |
| Q1 2026 | $144M | 186.4K | — | — |
| Q4 2025 | $158.5M | 205.3K | — | — |
| Q4 2025 | $158.5M | 205.3K | — | — |
| Q3 2025 | $95.3M | 169.5K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B